In a letter (PDF) to shareholders, executives said the company has a legal pathway to sell "personalized titration schedules and dosage levels that are not essentially copies of commercially available medications" that allow providers to "meet the needs of individual patients regardless of shortage dynamics." Hims & Hers said revenue from its non-GLP-1 offerings totaled $1.2 billion of the $1.48 billion that it brought in last year, suggesting the company sold roughly $200 million in compounded GLP-1 drugs last year

Step 3: Gather your supplies Before your first injection, you need the following items ready: Insulin syringes (1 mL/100 unit or 0.5 mL/50 unit, with 29-31 gauge needles) Alcohol swabs (for cleaning vial top and injection site) Sharps container (for safe needle disposal) Your compounded tirzepatide vial Bacteriostatic water (only if your vial requires reconstitution ) A tracking journal or app (for logging doses, side effects, weight, and measurements) For microdosing specifically, 0.5 mL (50 unit) syringes offer better precision than 1 mL syringes because each unit marking represents a smaller volume
The explanation for the discrepancy in the reduction of MACE in patients treated with SGLT2i in DECLARE-TIMI 58 suggests that the benefits of SGLT2i may be more pronounced in patients with a higher risk of cardiovascular disease
38.7%) and suicidal ideation (n = 73
Jensen, E
Why might some people notice skin changes on GLP-1 treatment